Premium Nahrungsergänzungsmittel | artgerecht

Chondrocyte Therapy Protocol: Steps & Treatment

The chondrocyte therapy protocol is a standardized treatment plan for cartilage cell therapy, used to repair cartilage defects in joints such as the knee.

Regular tips about health Regular tips about health

Things worth knowing about "Chondrocyte therapy protocol"

The chondrocyte therapy protocol is a standardized treatment plan for cartilage cell therapy, used to repair cartilage defects in joints such as the knee.

What is the Chondrocyte Therapy Protocol?

The chondrocyte therapy protocol is a structured medical treatment plan that outlines every step of chondrocyte therapy – a treatment using cartilage cells – from initial diagnosis through to aftercare and rehabilitation. It serves as a clinical guideline for physicians and patients alike, ensuring the entire treatment process is safe, transparent, and effective. This protocol is most commonly applied in the treatment of cartilage defects in the knee joint, but it is also used in other joints such as the hip, ankle, and shoulder.

Indications

The chondrocyte therapy protocol is indicated for:

Focal cartilage defects (localized cartilage damage) in joints
Cartilage injuries resulting from sports injuries or trauma (e.g., osteochondritis dissecans)
Degenerative cartilage damage in early stages of osteoarthritis
Failed previous cartilage repair procedures (e.g., microfracture surgery)

The goal is to restore cartilage structure and function as completely as possible in order to relieve pain and preserve long-term joint function.

Protocol Steps

1. Diagnosis and Patient Selection

Before therapy begins, a thorough diagnostic workup is performed, including imaging techniques such as MRI (magnetic resonance imaging) or arthroscopy. The size, depth, and location of the cartilage defect are assessed. Only suitable patients – typically younger individuals with well-defined defects and without advanced osteoarthritis – are selected for the procedure.

2. Cartilage Cell Harvesting (Biopsy)

In a first minimally invasive procedure (arthroscopy), a small sample of healthy cartilage tissue is taken from a less load-bearing area of the affected joint. This sample contains the chondrocytes (cartilage cells) that are subsequently processed in a laboratory.

3. Cell Expansion in the Laboratory (In Vitro Expansion)

The harvested chondrocytes are cultured and multiplied under sterile conditions in a specialized laboratory. This process typically takes 3 to 6 weeks. The cell count is increased to a sufficient number for subsequent transplantation.

4. Reimplantation of Cartilage Cells

In a second surgical procedure, the expanded chondrocytes are introduced into the cartilage defect. Several techniques are available:

Autologous chondrocyte implantation (ACI): Cells are injected beneath a periosteal flap or a collagen membrane covering the defect.
Matrix-associated autologous chondrocyte implantation (MACI): Cells are cultured on a carrier material (e.g., collagen matrix) and implanted as a graft.

5. Aftercare and Rehabilitation

Aftercare is a central component of the protocol. It includes a controlled and gradual increase in weight-bearing, physiotherapy, and regular follow-up examinations. Full return to sports activity is typically achieved after 12 to 18 months. Pain relievers and anti-inflammatory medications may be used as part of the supportive treatment.

Outcomes and Evidence

Clinical studies demonstrate that autologous chondrocyte implantation can lead to significant pain reduction and improvement in joint function in appropriately selected patients. The quality of life of the majority of treated patients improves sustainably. Success rates are strongly influenced by correct patient selection, the quality of cell preparation, and consistent adherence to rehabilitation protocols.

Risks and Complications

Infection at the surgical site
Overgrowth of the transplant (periosteal hypertrophy)
Incomplete integration of the new cartilage tissue
General surgical risks (thrombosis, anesthesia-related complications)

References

Brittberg M. et al. - Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte Transplantation. New England Journal of Medicine, 1994; 331(14):889-895.
Minas T., Nehrer S. - Current Concepts in the Treatment of Articular Cartilage Defects. Orthopedics, 1997; 20(6):525-538.
German Society for Orthopaedics and Trauma Surgery (DGOU) - Guideline on Cartilage Repair, 2021. Available at: www.dgou.de

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category